HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Liping Wang Selected Research

Esophageal Neoplasms (Esophageal Cancer)

1/2023Outcomes of intravenous and inhalation anesthesia on patients undergoing esophageal cancer surgery: a retrospective observational study.
5/2017LncRNA Snhg1, a non-degradable sponge for miR-338, promotes expression of proto-oncogene CST3 in primary esophageal cancer cells.
1/2017Clinical significance of serum cathepsin B and cystatin C levels and their ratio in the prognosis of patients with esophageal cancer.
5/2016Long noncoding RNA MALAT1 promotes malignant development of esophageal squamous cell carcinoma by targeting β-catenin via Ezh2.
8/2015Transforming growth factor-beta1 promotes the migration and invasion of sphere-forming stem-like cell subpopulations in esophageal cancer.
11/2014[Expression and clinical significance of CCL5 in patients with esophageal carcinoma].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Liping Wang Research Topics

Disease

220Neoplasms (Cancer)
05/2024 - 05/2002
45Infections
05/2024 - 06/2003
41Inflammation (Inflammations)
11/2023 - 10/2011
38Breast Neoplasms (Breast Cancer)
11/2023 - 02/2008
29Neoplasm Metastasis (Metastasis)
02/2024 - 02/2008
18Stroke (Strokes)
01/2023 - 07/2008
17Carcinoma (Carcinomatosis)
12/2023 - 05/2009
16Lung Neoplasms (Lung Cancer)
02/2024 - 04/2015
16Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2024 - 01/2018
16Pain (Aches)
10/2023 - 07/2011
14Hepatocellular Carcinoma (Hepatoma)
05/2024 - 01/2015
13Urinary Bladder Neoplasms (Bladder Cancer)
05/2024 - 10/2016
13Ischemic Stroke
01/2023 - 10/2015
12Insulin Resistance
11/2023 - 01/2009
11Prostatic Neoplasms (Prostate Cancer)
01/2022 - 06/2014
10Hypoxia (Hypoxemia)
11/2023 - 01/2009
10Glioma (Gliomas)
07/2023 - 06/2014
10Reperfusion Injury
01/2023 - 01/2009
10Type 2 Diabetes Mellitus (MODY)
01/2021 - 01/2005
9Melanoma (Melanoma, Malignant)
03/2024 - 08/2010
9Colorectal Neoplasms (Colorectal Cancer)
02/2024 - 01/2019
9Stomach Neoplasms (Stomach Cancer)
12/2023 - 07/2013
9Carcinogenesis
01/2023 - 01/2013
9Osteoporosis
12/2021 - 09/2012
8Periodontitis
03/2024 - 01/2020
8Cardiovascular Diseases (Cardiovascular Disease)
03/2024 - 05/2012
8Wounds and Injuries (Trauma)
02/2024 - 02/2014
8Obesity
01/2024 - 01/2009
8Adenocarcinoma of Lung
01/2024 - 05/2017
8COVID-19
08/2023 - 01/2020
8Ischemia
01/2023 - 01/2017
8Brain Ischemia (Cerebral Ischemia)
01/2023 - 10/2016
8Esophageal Squamous Cell Carcinoma
10/2022 - 01/2015
7Bacterial Infections (Bacterial Infection)
05/2024 - 01/2018
7Fibrosis (Cirrhosis)
01/2024 - 07/2012
7Edema (Dropsy)
12/2023 - 08/2009
7Atherosclerosis
01/2023 - 10/2015
6Communicable Diseases (Infectious Diseases)
04/2024 - 10/2018
6Myocardial Infarction
03/2024 - 01/2013
6Small Cell Lung Carcinoma (Small Cell Lung Cancer)
02/2024 - 05/2002
6Parkinson Disease (Parkinson's Disease)
12/2023 - 10/2018
6Esophageal Neoplasms (Esophageal Cancer)
01/2023 - 11/2014
6Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2023 - 11/2017
6Thyroid Neoplasms (Thyroid Cancer)
01/2022 - 11/2014
6Cognitive Dysfunction
01/2022 - 01/2012
6Alzheimer Disease (Alzheimer's Disease)
02/2021 - 01/2012
5Thrombosis (Thrombus)
08/2023 - 07/2013

Drug/Important Bio-Agent (IBA)

79Proteins (Proteins, Gene)FDA Link
03/2024 - 08/2007
34Biomarkers (Surrogate Marker)IBA
01/2024 - 06/2014
32CytokinesIBA
02/2024 - 07/2011
29Messenger RNA (mRNA)IBA
03/2024 - 06/2003
20MicroRNAs (MicroRNA)IBA
12/2023 - 01/2013
15EnzymesIBA
01/2024 - 03/2007
15Peptides (Polypeptides)IBA
04/2023 - 07/2010
14Therapeutic UsesIBA
02/2024 - 07/2008
14Long Noncoding RNAIBA
12/2023 - 05/2016
13Small Interfering RNA (siRNA)IBA
10/2023 - 03/2014
12RNA (Ribonucleic Acid)IBA
04/2024 - 01/2017
12Glucose (Dextrose)FDA LinkGeneric
12/2023 - 01/2009
11VaccinesIBA
04/2024 - 12/2004
11Reactive Oxygen Species (Oxygen Radicals)IBA
02/2024 - 07/2012
11LigandsIBA
12/2022 - 04/2012
10AntioxidantsIBA
11/2023 - 01/2014
10Interleukin-6 (Interleukin 6)IBA
12/2022 - 11/2012
8Oxygen (Dioxygen)IBA
12/2023 - 01/2009
8Blood Glucose (Blood Sugar)IBA
11/2023 - 01/2009
8Anti-Bacterial Agents (Antibiotics)IBA
01/2023 - 09/2014
8ChemokinesIBA
01/2022 - 10/2011
8AntigensIBA
01/2022 - 04/2014
7AcidsIBA
05/2024 - 08/2011
7HMGB1 Protein (HMG1)IBA
12/2023 - 01/2015
7Immune Checkpoint InhibitorsIBA
07/2023 - 07/2022
7CateninsIBA
01/2022 - 01/2016
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019 - 06/2006
6CollagenIBA
03/2024 - 10/2011
6deuterohemin- alanyl- histidyl- threonyl- valyl- glutamyl- lysineIBA
04/2023 - 07/2010
6salicylhydroxamic acid (SHAM)IBA
01/2023 - 07/2008
6Insulin (Novolin)FDA Link
01/2022 - 01/2009
6Glutamine (L-Glutamine)FDA Link
01/2022 - 01/2018
6Matrix Metalloproteinases (MMPs)IBA
01/2020 - 11/2013
5HydrogelsIBA
02/2024 - 01/2021
5HydrogenIBA
12/2023 - 10/2016
5Triglycerides (Triacylglycerol)IBA
11/2023 - 01/2009
5Fatty Acids (Saturated Fatty Acids)IBA
11/2023 - 09/2014
5CeramidesIBA
11/2023 - 10/2018
5Superoxide DismutaseIBA
11/2023 - 01/2009
5InterleukinsIBA
10/2023 - 07/2011
5Immunoglobulin G (IgG)IBA
08/2023 - 05/2018
5DNA (Deoxyribonucleic Acid)IBA
07/2023 - 04/2014

Therapy/Procedure

93Therapeutics
05/2024 - 03/2007
31Immunotherapy
05/2024 - 04/2014
30Drug Therapy (Chemotherapy)
02/2024 - 11/2010
9Lasers (Laser)
02/2024 - 09/2012
9Transplantation
01/2023 - 08/2014
8Radiotherapy
03/2024 - 08/2015
8Aftercare (After-Treatment)
01/2023 - 06/2015
7Length of Stay
04/2023 - 07/2008
7Photothermal Therapy
01/2022 - 09/2012
5Chinese Traditional Medicine (Traditional Chinese Medicine)
05/2024 - 08/2010
5Neoadjuvant Therapy
12/2023 - 07/2018